Clinical trial
An Open-Label, Single-Center, Phase I Study on the Safety of Abatacept in Relapsing Polychondritis
NCT01272856 is registered in ClinicalTrials.gov with Benaroya Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, Single-Center, Phase I Study on the Safety of Abatacept in Relapsing Polychondritis
- Lead sponsor
- Benaroya Research Institute
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2011
- Completion date
- May 31, 2012
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
relapsing polychondritis